Literature DB >> 25337041

Role of chemokines in renal cell carcinoma.

Jaspreet S Parihar1, Hari S G R Tunuguntla1.   

Abstract

With new frontiers of pharmaceutical therapies focusing on tumor growth and angiogenesis, understanding the interaction between immune system and tumor microenvironment has become ever more important. Chemokines and chemokine receptors appear to play an integral role in tumor characteristics. Evidence suggests CXCR4, CXCL5, CXCR7, and stromal derived factor-1 appear to be crucial in survival, growth, and metastasis of renal cell carcinoma. As the role of chemokines in renal cancer is becoming more evident, further research will lead to a better understanding of tumor biology and the development of new therapeutic targets to help improve survival.

Entities:  

Keywords:  Chemokine; Cytokines; Oncocytoma; Renal cell carcinoma

Year:  2014        PMID： 25337041      PMCID： PMC4191631     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


  24 in total

Review 1.  Tumor-host interactions: a far-reaching relationship.

Authors:  Sandra S McAllister; Robert A Weinberg
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

Review 2.  Renal-cell carcinoma.

Authors:  Herbert T Cohen; Francis J McGovern
Journal:  N Engl J Med       Date:  2005-12-08       Impact factor: 91.245

3.  The differential expression of proinflammatory cytokines IL-6, IL-8 and TNF-alpha in renal cell carcinoma.

Authors:  B König; F Steinbach; B Janocha; A Drynda; M Stumm; C Philipp; E P Allhoff; W König
Journal:  Anticancer Res       Date:  1999 Mar-Apr       Impact factor: 2.480

Review 4.  Chemokine receptors.

Authors:  R Horuk
Journal:  Cytokine Growth Factor Rev       Date:  2001-12       Impact factor: 7.638

5.  Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion.

Authors:  David Zagzag; Yevgeniy Lukyanov; Li Lan; M Aktar Ali; Mine Esencay; Olga Mendez; Herman Yee; Evelyn B Voura; Elizabeth W Newcomb
Journal:  Lab Invest       Date:  2006-10-30       Impact factor: 5.662

6.  Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.

Authors:  Merav Darash-Yahana; Eli Pikarsky; Rinat Abramovitch; Evelyne Zeira; Boaz Pal; Rebekah Karplus; Katia Beider; Shani Avniel; Shafika Kasem; Eithan Galun; Amnon Peled
Journal:  FASEB J       Date:  2004-06-04       Impact factor: 5.191

7.  Calcineurin inhibitors modulate CXCR3 splice variant expression and mediate renal cancer progression.

Authors:  Dipak Datta; Alan G Contreras; Martin Grimm; Ana Maria Waaga-Gasser; David M Briscoe; Soumitro Pal
Journal:  J Am Soc Nephrol       Date:  2008-10-02       Impact factor: 10.121

8.  Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression.

Authors:  M A López-Lago; S Posner; V J Thodima; A M Molina; R J Motzer; R S K Chaganti
Journal:  Oncogene       Date:  2012-06-04       Impact factor: 9.867

9.  A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development.

Authors:  Jennifer M Burns; Bretton C Summers; Yu Wang; Anita Melikian; Rob Berahovich; Zhenhua Miao; Mark E T Penfold; Mary Jean Sunshine; Dan R Littman; Calvin J Kuo; Kevin Wei; Brian E McMaster; Kim Wright; Maureen C Howard; Thomas J Schall
Journal:  J Exp Med       Date:  2006-08-28       Impact factor: 14.307

10.  Depletion of intrinsic expression of Interleukin-8 in prostate cancer cells causes cell cycle arrest, spontaneous apoptosis and increases the efficacy of chemotherapeutic drugs.

Authors:  Rajendra K Singh; Bal L Lokeshwar
Journal:  Mol Cancer       Date:  2009-07-31       Impact factor: 27.401
View more
  11 in total

1.  Reduced expression of CXCR4, a novel renal cancer stem cell marker, is associated with high-grade renal cell carcinoma.

Authors:  Arezoo Rasti; Maryam Abolhasani; Leili Saeednejad Zanjani; Mojgan Asgari; Mitra Mehrazma; Zahra Madjd
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-16       Impact factor: 4.553

2.  MicroRNA-1 and MicroRNA-21 Individually Regulate Cellular Growth of Non-malignant and Malignant Renal Cells.

Authors:  Hannes Ahrend; Anne Kaul; Susanne Ziegler; Lars-Ove Brandenburg; Uwe Zimmermann; Alexander Mustea; Martin Burchardt; Patrick Ziegler; Matthias B Stope
Journal:  In Vivo       Date:  2017 Jul-Aug       Impact factor: 2.155

3.  IL-6 is involved in malignancy and doxorubicin sensitivity of renal carcinoma cells.

Authors:  Yanqiang Chen; Jianzhen Liu; Pei Lv; Jiangyan Gao; Mingzheng Wang; Yongjun Wang
Journal:  Cell Adh Migr       Date:  2017-06-19       Impact factor: 3.405

4.  Cytokines in Renal Cell Carcinoma: A Step Towards Earlier Detection and Targeted Therapy.

Authors:  Daniela Vargová; Ján Ľupták; Ján Dargaj; Soňa Fraňová; Michaela Kocmálová; Juraj Šutovský; Ján Švihra; Ingrid Škorňová; Pavol Slávik; Marián Grendár; Ján Švihra; Lukáš Briš; Martina Šutovská
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

5.  The SDF-1/CXCR4 chemokine axis in uveal melanoma cell proliferation and migration.

Authors:  Jianjun Bi; Peng Li; Chuanyin Li; Jie He; Ying Wang; He Zhang; Xianqun Fan; Renbing Jia; Shengfang Ge
Journal:  Tumour Biol       Date:  2015-10-22

Review 6.  Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation.

Authors:  Selma Rivas-Fuentes; Alfonso Salgado-Aguayo; Silvana Pertuz Belloso; Patricia Gorocica Rosete; Noé Alvarado-Vásquez; Guillermo Aquino-Jarquin
Journal:  J Cancer       Date:  2015-08-07       Impact factor: 4.207

7.  Different Cytokine and Chemokine Expression Patterns in Malignant Compared to Those in Nonmalignant Renal Cells.

Authors:  Nadine Gelbrich; Hannes Ahrend; Anne Kaul; Lars-Ove Brandenburg; Uwe Zimmermann; Alexander Mustea; Martin Burchardt; Denis Gümbel; Matthias B Stope
Journal:  Anal Cell Pathol (Amst)       Date:  2017-07-09       Impact factor: 2.916

8.  PBRM1 regulates proliferation and the cell cycle in renal cell carcinoma through a chemokine/chemokine receptor interaction pathway.

Authors:  HongKai Wang; YuanYuan Qu; Bo Dai; Yao Zhu; GuoHai Shi; YiPing Zhu; YiJun Shen; HaiLiang Zhang; DingWei Ye
Journal:  PLoS One       Date:  2017-08-28       Impact factor: 3.240

9.  Enhanced IMP3 Expression Activates NF-кB Pathway and Promotes Renal Cell Carcinoma Progression.

Authors:  Xuelian Pei; Muhan Li; Jun Zhan; Yu Yu; Xiaofan Wei; Lizhao Guan; Hakan Aydin; Paul Elson; Ming Zhou; Huiying He; Hongquan Zhang
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

10.  TNF-α augments CXCR2 and CXCR3 to promote progression of renal cell carcinoma.

Authors:  Kuang-Hui Sun; Guang-Huan Sun; Yi-Ching Wu; Bai-Jiun Ko; Hui-Tzu Hsu; Sheng-Tang Wu
Journal:  J Cell Mol Med       Date:  2016-06-14       Impact factor: 5.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.